Article

Limited Cross-Variant Immune Response From SARS-CoV-2 Omicron BA.2 in Naïve But Not Previously Infected Outpatients

2022-05-31

Abstract excerpt

Omicron is currently the dominant SARS-CoV-2 variant and several sublineages have emerged. Questions remain about the impact of previous SARS-CoV-2 exposure on cross-variant immune responses elicited by BA.2 infection compared to BA.1. Here we show that without previous history of COVID-19, BA.2 infection induces a reduced immune response against all variants of concern (VOC) compared to BA.1 infection. The absenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1a8fc448-601a-581a-ba1b-5666d663bfda
DOI: 10.2139/ssrn.4124623

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Limited Cross-Variant Immune Response From SARS-CoV-2 Omicron BA.2 in Naïve But Not Previously Infected OutpatientsDOI 10.2139/ssrn.4124623Read

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsSemantic proximity Read

Infection of Omicron BA.5.2 in patients provides broad immune responses against SARS-CoV-2Semantic proximity Read

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsSemantic proximity Read

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.Semantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read

Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19Semantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of ConcernSemantic proximity Read

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.Semantic proximity Read

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75Semantic proximity Read

Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.Semantic proximity Read

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsSemantic proximity Read

SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasionSemantic proximity Read